-
公开(公告)号:WO2022072512A1
公开(公告)日:2022-04-07
申请号:PCT/US2021/052674
申请日:2021-09-29
申请人: METACRINE, INC.
发明人: HUDSON, Andrew R. , GOVEK, Steven P. , NAGASAWA, Johnny Y. , BOTROUS, Iriny , SMITH, Nicholas D. , FASANYA, Karensa L.
IPC分类号: A61K31/34 , A61K31/39 , A61K31/40 , A61K31/537 , A61P29/00
摘要: Described herein are compounds that are HSD17B13 inhibitors, methods of making such compounds, pharmaceutical compositions and medicaments comprising such compounds, and methods of using such compounds in the treatment of conditions, diseases, or disorders associated with HSD17B13 activity.
-
公开(公告)号:WO2022072517A1
公开(公告)日:2022-04-07
申请号:PCT/US2021/052679
申请日:2021-09-29
申请人: METACRINE, INC.
发明人: HUDSON, Andrew R. , GOVEK, Steven P. , NAGASAWA, Johnny Y. , BOTROUS, Iriny , SMITH, Nicholas D. , FASANYA, Karensa L.
IPC分类号: A61K31/34 , A61K31/39 , A61K31/40 , A61K31/537 , A61P29/00
摘要: Described herein are compounds that are HSD17B13 inhibitors, methods of making such compounds, pharmaceutical compositions and medicaments comprising such compounds, and methods of using such compounds in the treatment of conditions, diseases, or disorders associated with HSD17B13 activity.
-
公开(公告)号:WO2020086747A3
公开(公告)日:2020-04-30
申请号:PCT/US2019/057707
申请日:2019-10-23
申请人: METACRINE, INC.
IPC分类号: A61K31/165 , C07C235/40 , C07C237/24
摘要: Described herein are compounds that are semicarbazide-sensitive amine oxidase (SSAO) inhibitors, methods of making such compounds, pharmaceutical compositions and medicaments comprising such compounds, and methods of using such compounds in treating or preventing a liver disease or condition.
-
公开(公告)号:WO2023043836A1
公开(公告)日:2023-03-23
申请号:PCT/US2022/043527
申请日:2022-09-14
申请人: METACRINE, INC.
发明人: NAGASAWA, Johnny Y. , BOTROUS, Iriny , LAI, Andiliy G. , HUDSON, Andrew R. , SMITH, Nicholas D. , GOVEK, Steven P.
IPC分类号: C07D401/10 , C07D403/04 , C07D403/10 , C07D413/04 , C07D413/10 , C07D471/04 , C07D487/04 , C07D401/14 , A61K31/4192 , A61K31/444 , A61K31/496 , A61K31/519 , A61K31/5377 , A61P1/16
摘要: Described herein are compounds that are HSD17B13 inhibitors, methods of making such compounds, pharmaceutical compositions and medicaments comprising such compounds, and methods of using such compounds in the treatment of conditions, diseases, or disorders associated with HSD17B13 activity.
-
公开(公告)号:WO2020086747A2
公开(公告)日:2020-04-30
申请号:PCT/US2019/057707
申请日:2019-10-23
申请人: METACRINE, INC.
IPC分类号: A61K31/325
摘要: Described herein are compounds that are semicarbazide-sensitive amine oxidase (SSAO) inhibitors, methods of making such compounds, pharmaceutical compositions and medicaments comprising such compounds, and methods of using such compounds in treating or preventing a liver disease or condition.
-
-
-
-